NCT05038371View on ClinicalTrials.gov

Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration

TerminatedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

September 1, 2022

Study Completion Date

September 22, 2022

Conditions
Wet Macular Degeneration
Trial Locations (1)

21287

Wilmer Eye Institute at Johns Hopkins University, Baltimore

Sponsors
All Listed Sponsors
collaborator

Olix Pharmaceuticals, Inc.

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT05038371 - Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration | Biotech Hunter | Biotech Hunter